Olivia B. Taylor on July 30, 2026 6:56 pm Silver leverage is strong here; beta cuts both ways though. Reply
Isabella Lopez on July 30, 2026 6:58 pm Interesting update on Testing the RM338: The 50 CAL Replacement with Unbelievably Light Recoil. Curious how the grades will trend next quarter. Reply
Patricia Q. Taylor on July 30, 2026 6:59 pm Exploration results look promising, but permitting will be the key risk. Reply
Michael Garcia on July 30, 2026 7:00 pm Uranium names keep pushing higher—supply still tight into 2026. Reply
Jennifer Garcia on July 30, 2026 7:02 pm Interesting update on Testing the RM338: The 50 CAL Replacement with Unbelievably Light Recoil. Curious how the grades will trend next quarter. Reply
Elizabeth Jackson on July 30, 2026 7:03 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Patricia Rodriguez on July 30, 2026 7:04 pm Silver leverage is strong here; beta cuts both ways though. Reply
Michael Smith on July 30, 2026 7:04 pm Exploration results look promising, but permitting will be the key risk. Reply
Emma Johnson on July 30, 2026 7:05 pm Exploration results look promising, but permitting will be the key risk. Reply
James Thompson on July 30, 2026 7:09 pm Nice to see insider buying—usually a good signal in this space. Reply
Oliver Thompson on July 30, 2026 7:09 pm Interesting update on Testing the RM338: The 50 CAL Replacement with Unbelievably Light Recoil. Curious how the grades will trend next quarter. Reply
Amelia Martin on July 30, 2026 7:09 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
Emma T. Brown on July 30, 2026 7:10 pm Interesting update on Testing the RM338: The 50 CAL Replacement with Unbelievably Light Recoil. Curious how the grades will trend next quarter. Reply
Michael Miller on July 30, 2026 7:10 pm Silver leverage is strong here; beta cuts both ways though. Reply
Elizabeth Lee on July 30, 2026 7:11 pm The cost guidance is better than expected. If they deliver, the stock could rerate. Reply
34 Comments
Silver leverage is strong here; beta cuts both ways though.
Interesting update on Testing the RM338: The 50 CAL Replacement with Unbelievably Light Recoil. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Exploration results look promising, but permitting will be the key risk.
Uranium names keep pushing higher—supply still tight into 2026.
Interesting update on Testing the RM338: The 50 CAL Replacement with Unbelievably Light Recoil. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Silver leverage is strong here; beta cuts both ways though.
Exploration results look promising, but permitting will be the key risk.
Exploration results look promising, but permitting will be the key risk.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Nice to see insider buying—usually a good signal in this space.
Good point. Watching costs and grades closely.
Interesting update on Testing the RM338: The 50 CAL Replacement with Unbelievably Light Recoil. Curious how the grades will trend next quarter.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Interesting update on Testing the RM338: The 50 CAL Replacement with Unbelievably Light Recoil. Curious how the grades will trend next quarter.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
I like the balance sheet here—less leverage than peers.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.
Silver leverage is strong here; beta cuts both ways though.
Good point. Watching costs and grades closely.
The cost guidance is better than expected. If they deliver, the stock could rerate.
Good point. Watching costs and grades closely.
Good point. Watching costs and grades closely.